A roundup of the latest news from pharma in the Middle East and Africa including China’s announcement that it will be prioritising Africa for access to its COVID-19 vaccine, UAE firm Mubadala’s latest US investment, Saudi Arabia’s continuing digitalisation push, and Algeria’s plan to export USD five billion in domestically produced medicines.


China: Africa to have priority access to COVID-19 vaccine (The Africa Report)

Chinese President Xi Jinping reiterated his oft-stated promise that developing countries, specifically those in Africa, will receive priority access to a Chinese-produced COVID-19 vaccine when it’s available for distribution.



UAE’s Mubadala invests in US pharma business (Arabian Business)

Senior Mubadala exec says outsourced pharmaceutical services has been a key investment theme for the sovereign investor



Saudi hospital to open with new medication dispensing tech (Healthcare Global)

New digital services at hospital will support Saudi’s healthcare infrastructure transformation. Omnicell, a US-based pharmacy and medication management solutions company, has partnered with the Imam Abdulrahman Bin Faisal University Hospital in Eastern Province, Saudi Arabia. The company will manage a pharmacy automation system for inpatients, allowing pharmacists to schedule medication dispensing.



Japanese pharma group Kyowa Kirin opens office in Dubai (Trade Arabia)

Leading Japan-based specialty pharmaceutical company Kyowa Kirin International has announced the opening of its new office in Dubai Healthcare City.

The new regional representative office was inaugurated by Dr Amin Hussein Al Amiri, Assistant Under-Secretary for Public Health Policy and Licensing Sector in the Ministry of Health and Prevention (MoHAP). With this launch, the total number of scientific offices operating in the UAE has risen to 78.



Jamjoom Pharmaceuticals Earns Acclaim from Frost & Sullivan for its Dominance in the KSA Pharma Market with its Expanded Portfolio and Geographic Presence (Frost & Sullivan)

Based on its recent analysis of the KSA emerging generic pharmaceuticals market, Frost & Sullivan recognizes Saudi Arabia-headquartered Jamjoom Pharmaceuticals with the 2020 KSA Company of the Year Award for its operational excellence and expanded product portfolio and footprint.



Algeria looks to export USD five billion in home-manufactured medicine (The North Africa Post)

Algeria is aiming at exporting USD five  billion of manufactured medicine with help of local producer, Lotfi Benbahmed, according to the country’s Minister of the Pharmaceutical Industry.